Loading quotes...
Forecast
The analysts' average price target is €11.37 (+39.00%). The median is €11.37 (+39.00%).
| Buy |
1 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
Cresud issues 60.6m new shares after exercise of warrants
After the exercise of 48,057,889 warrants, Cresud issued 60,565,872 new common shares, raising $11,119,194. The number of outstanding common shares increased from 648,742,437 to 709,308,309. After the exercises, 1,650,742 warrants remained unexercised and expired on March 10. » More on de.investing.com
Cresud calls general meeting for 30 October – dividend and board compensation on agenda
Cresud convenes an ordinary and extraordinary general meeting on 30 October (virtual, with a possible second session at 15:30). Shareholders will be asked to review the financial statements for the year ended 30 June 2025 and the appropriation of net profit of 75,608,298,323.55 ARS, as well as undistributed prior-year results of 19,480,344,053.25 ARS and a proposed dividend distribution of up to 88,500,000,000 ARS (in cash and/or scrip dividend). Other items include the approval and setting of remuneration for the board of directors (686,090,660.27 ARS) and the supervisory body (31,559,086 ARS), committee reappointments, election and remuneration of the external auditor, a warrant addendum for share-based exercise, the issuance of up to 5,300,000 treasury shares, and the audit committee’s annual budget. Registration to participate closes on 24 October 2025 at 15:00 local time; the meeting will be held via Zoom with verification and voting procedures. » More on de.investing.com
Cresud successfully places $43.7 million bond on Argentine capital market
Cresud has placed debt securities totaling $43.7 million on the Argentine capital market at an interest rate of 8.00%. The Series XLVIII bonds will be issued on July 11, 2025, and mature on July 11, 2028, with interest payments made semiannually. The principal will be repaid in a single payment at maturity. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 244.35M | 52.82% |
| Gross profit | 100.49M | 29.39% |
| Net profit | 32.82M | 36.96% |
| EBITDA | 45.79M | 26.91% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €580.4M |
Number of shares | 70.93M |
52-week high/low | €12.74 - €8.01 |
Dividend yield | 9.77% |
Dividends TTM | €0.80 |
Beta | -0.06 |
P/E ratio | 5.74 |
PEG ratio | 0.14 |
P/B ratio | 0.66 |
P/S ratio | 0.83 |
Company profile
Cresud Sociedad Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria, an agricultural company, produces basic agricultural commodities in Brazil and other Latin American countries. It operates through Agricultural Business, and Urban Properties and Investment Business segments. The Agricultural Business segment is involved in the planting, harvesting, and sale of crops, such as wheat, corn, soybeans, cotton, and sunflower, as well as sugarcane; sale of grain derivatives, including flour and oil; breeding, purchasing, and/or fattening of cattle for sale to meat processors and local livestock auction markets; provision of agricultural services; leasing of farms to third parties; disposal and development of farmlands; and brokerage activities. The Urban Properties and Investment Business segment leases, rents, and services commercial and other spaces in shopping malls; leases offices and other rental spaces; develops, maintains, and sells undeveloped parcels of land and/or trading properties; and operates hotels, as well as engages in the entertainment activities. The company was incorporated in 1936 and is headquartered in Buenos Aires, Argentina.
| Name | Cresud Com. Ind.Fin.yAgro. ADR |
| CEO | Alejandro Gustavo Elsztain |
| Headquarters | Buenos Aires,
ba Argentina |
| Website | |
| Sector | Industrials |
| Industry | Industrial Conglomerates |
| IPO | 03/19/1997 |
| Employees | 2,760 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NASDAQ | CRESY |
Frankfurt | CD8.F |
Düsseldorf | CD8.DU |
München | CD8.MU |